Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Up 100.8% in December

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 26,100 shares, a growth of 100.8% from the November 30th total of 13,000 shares. Based on an average trading volume of 58,400 shares, the days-to-cover ratio is currently 0.4 days.

Cardio Diagnostics Stock Performance

Shares of CDIOW stock traded up $0.01 on Friday, hitting $0.10. The stock had a trading volume of 23,626 shares, compared to its average volume of 31,163. Cardio Diagnostics has a one year low of $0.02 and a one year high of $0.28. The business has a 50 day moving average price of $0.05 and a 200 day moving average price of $0.04.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.